S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
New CBOE “special perk” helps traders target income every weekend (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
New CBOE “special perk” helps traders target income every weekend (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
New CBOE “special perk” helps traders target income every weekend (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
New CBOE “special perk” helps traders target income every weekend (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Vivani Medical Stock Price, News & Analysis (NASDAQ:VANI)

$0.94
-0.01 (-1.05%)
(As of 12/5/2023 ET)
Compare
Today's Range
$0.94
$1.00
50-Day Range
$0.94
$1.13
52-Week Range
$0.75
$1.89
Volume
26,874 shs
Average Volume
48,616 shs
Market Capitalization
$48.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VANI stock logo

About Vivani Medical Stock (NASDAQ:VANI)

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

VANI Stock Price History

VANI Stock News Headlines

Vivani Medical: Q3 Earnings Insights
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Vivani Medical GAAP EPS of -$0.13
Vivani Medical Inc VANI
Vivani Medical, Inc. (VANI)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Vivani Medical to Present at BIO Investor Forum
Vivani Medical Director Trades $97K In Company Stock
Insider Buys Additional US$50k In Vivani Medical Stock
50K Reasons To Be Bullish On Vivani Medical Stock
Vivani Medical to Present at the Boulder Peptide Symposium
Maxim Group Reaffirms Their Buy Rating on Vivani Medical (VANI)
Vivani Medical GAAP EPS of -$0.13 misses by $0.02
Vivani Medical: Q2 Earnings Snapshot
See More Headlines
Receive VANI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/29/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VANI
Employees
50
Year Founded
N/A

Profitability

Net Income
$-13,890,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.87 per share

Miscellaneous

Free Float
22,645,000
Market Cap
$48.21 million
Optionable
Optionable
Beta
2.43
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report














VANI Stock Analysis - Frequently Asked Questions

How have VANI shares performed in 2023?

Vivani Medical's stock was trading at $0.8497 at the start of the year. Since then, VANI stock has increased by 11.2% and is now trading at $0.9447.
View the best growth stocks for 2023 here
.

When is Vivani Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our VANI earnings forecast
.

How were Vivani Medical's earnings last quarter?

Vivani Medical, Inc. (NASDAQ:VANI) released its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.13) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.13).

Who are Vivani Medical's major shareholders?

Vivani Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Cutler Group LLC CA (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aaron Mendelsohn, Brigid Makes, Donald Dwyer, Gregg Williams and Joachim Eberhard Bolck.
View institutional ownership trends
.

How do I buy shares of Vivani Medical?

Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:VANI) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -